The intervention of valproic acid on the tumorigenesis induced by an environmental carcinogen of PAHs.

Publisher:
OXFORD UNIV PRESS
Publication Type:
Journal Article
Citation:
Toxicol Res (Camb), 2020, 9, (5), pp. 609-621
Issue Date:
2020-09
Full metadata record
This study investigated whether valproic acid (VPA, a histone deacetylase inhibitor) can interfere with the carcinogenicity of polycyclic aromatic hydrocarbons (PAHs). A typical representative compound of PAHs, 7,12-Dimethylbenz[a]anthracene (DMBA), was used to induce rat breast cancer. The results showed that therapeutic concentration of VPA (50 and 100 mg/kg) delayed the occurrence of tumors, reduced tumor formation rate and attenuated tumors growth, and have a protective effect on normal tissues. The macrophage-mediated inflammatory response was found to be associated with the observed effect of VPA. In addition, we screened and validated a possible gene, Sema3c, which was involved in DMBA-induced breast cancer development and can be inhibited by VPA.
Please use this identifier to cite or link to this item: